Vanderbilt investigators have discovered how mammals, including humans, produce the painkiller morphine.
Sabine Fuhrmann kicks off the CDB Monday Seminar Series on Aug. 31.
Vanderbilt has been recognized by the “Nashville Business Journal” as the Healthiest Employer of Nashville in the division for organizations with more than 500 employees. The recognition marks the sixth time in the six-year history of the award that Vanderbilt has won.
Vanderbilt’s Department of Medicine will host a mini-research retreat, on Aug. 29, at 202 Light Hall.
Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation.
Jeffrey Rathmell, Ph.D., has been recruited to Vanderbilt University Medical Center (VUMC) to lead a new Center for Immunobiology, a structure supported by the Department of Pathology, Microbiology and Immunology, the Department of Medicine and Vanderbilt-Ingram Cancer Center (VICC).